Inhibitex
Latest round
- Series D
Last raised
- Apr 2002
Total raised
- $60M
Investors
- 10
About Inhibitex
Founded in 1994 and based in Georgia, US, Inhibitex, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes antibody-based products for the prevention and treatment of fungal and bacterial infections in the hospital setting.
Who invested in Inhibitex
10 investors across 3 rounds
See all investors in Inhibitex
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Inhibitex
Who invested in Inhibitex?
Inhibitex has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inhibitex raised?
Inhibitex has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Inhibitex last raise money?
Inhibitex's most recent round on record is a Series D, in Apr 2002.
What does Inhibitex do?
Founded in 1994 and based in Georgia, US, Inhibitex, Inc.
Where is Inhibitex headquartered?
Inhibitex is headquartered in Alpharetta, US.
Which VCs invest in companies like Inhibitex?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Inhibitex's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Inhibitex? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.